Pfizer, Novartis lead USD 2 billion spending spree on gene therapy production Medical Dialogues Bureau28 Nov 2019 9:00 AM ISTNew Delhi: Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018,...
Pfizer Abrilada, biosimilar to Humira gets USFDA nod for multiple inflammatory conditions Farhat Nasim20 Nov 2019 12:44 PM ISTNew Delhi: Pfizer Inc. recently announced the United States (U.S.) Food and Drug Administration (USFDA) has approved ABRILADA (adalimumab-afzb), as a...
Mylan, Pfizer say Mylan-Upjohn combined entity to be known as Viatris Medical Dialogues Bureau16 Nov 2019 9:20 AM ISTNew Delhi: Mylan N.V. and Pfizer Inc. recently announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn,...
Pfizer cancer drug Ibrance higher sales beat Q3 profit estimates Medical Dialogues Bureau30 Oct 2019 9:30 AM ISTPfizer said it expects to earn between $2.94 per share and $3.00 per share, up from a prior estimate of $2.76 to $2.86. Analysts on average were...
GSK ovarian cancer drug Zejula gets USFDA nod for wider use Medical Dialogues Bureau24 Oct 2019 10:00 AM ISTZejula was the lead compound of U.S. cancer specialist Tesaro, which GSK acquired for $5.1 billion last year. Zejula brought in sales of 57 million...
Lindsay Goldberg to buy Bilcare Research in a deal worth USD 279-334 million: Report Medical Dialogues Bureau5 Sept 2019 9:00 AM ISTBilcare Research, which employs 1000 staff and has annual sales of 300 million euros, produces plastic packaging used in the pharmaceutical, consumer...
Mylan gets tentative USFDA nod for generic of Eli Lilly lung cancer drug Alimta Medical Dialogues Bureau31 Aug 2019 9:30 AM ISTAlimta is Lilly's third biggest-selling drug. The Indianapolis-based drugmaker reported second-quarter sales of $577.8 million for the medicine.U.S:...
Pfizer infuses Rs 3597 crore to expand gene therapy plant in Sanford Medical Dialogues Bureau22 Aug 2019 9:30 AM ISTThe investment will add additional capacity and capabilities to a facility that makes some of Pfizer's most closely watched experimental...
AbbVie wins USFDA nod for new rheumatoid arthritis drug priced at Rs 41 lakh per year Medical Dialogues Bureau18 Aug 2019 9:36 AM ISTA four-week supply of Humira, the world's best-selling medicine, has a list price of about $5,174, amounting to more than $60,000 for a year.U.S:...
Pfizer recalls 2 lots of migraine drug RELPAX over possible microbial contamination Farhat Nasim17 Aug 2019 9:14 AM ISTLots of Pfizer Inc's Relpax were distributed nationwide to wholesalers, retailers, hospitals and healthcare providers in the 50 states and Puerto Rico...
Pfizer, GSK completes transaction to form new consumer healthcare JV Medical Dialogues Bureau3 Aug 2019 9:40 AM ISTThe Joint Venture brings together two highly complementary portfolios of trusted consumer health brands, including GSK's Sensodyne, Voltaren and...
Pfizer, Mylan in talks to merge off-patent drugs business Medical Dialogues Bureau29 July 2019 9:30 AM ISTMylan shareholders would receive a little more than 40 per cent of the newly formed entity, with Pfizer shareholders receiving the remainder, the...
